Bei der Entstehung von Magengeschw}ren ist in den letzten
Jahren die Bedeutung einer Ausl sung durch Campylobacter
pylori bekannt geworden. Neue systematische Untersuchungen
f}hrten zu einer Namens{nderung: Helicobacter. Der Band gibt
eine Õbersicht }ber den derzeitigen Wissensstand.

Section 1 Virulence Factors and Pathogenicity of Helicobacter pylori

Urease and Catalase as Virulence Factors of Helicobacter pylori
Discussion
Adhesion Properties of Helicobacter pylori
Helicobacter pylori Hemagglutinins
Discussion
Cytotoxic Activity of Helicobacter pylori
Discussion
Helicobacter pylori and Gastric Mucus Integrity
Discussion
Helicobacter pylori and Other Gastric Spirilla: Similarities and Differences
Further Observations on Human Spirobacteria
Discussion
Animal Models of Helicobacter pylori Gastritis
Discussion
Isotype and Specificity of Local and Systemic Anti-Helicobacter pylori Antibodies
Discussion
Section 2 Epidemiology of Helicobacter pylori
Survival of Helicobacter pylori in the Aquatic Environment
Discussion
Helicobacter pylori in Human Populations: The Present and Predictions of the Future Based on the Epidemiology of Polio
Discussion
Transmission and Sources of Helicobacter pylori
Discussion
Chronic Gastritis: Epidemiology and Relationship to Peptic Ulcer Diseases
Gastritis Epidemiology and Natural History
Discussion
Epidemiology of Gastric Metaplasia
Discussion
Epidemiology of Duodenal Ulcer Disease
Discussion
Section 3 Theoretical Site of Helicobacter pylori Therapy
In Vitro Sensitivity of Helicobacter pylori
Discussion
Antibiotic Concentrations in Gastric Mucosa: The Guinea Pig Model
Discussion
Acquired Resistance to Antibiotics: An Underestimated Cause of Failure in the Treatment of Helicobacter pylori Infection
Discussion
Clinical Pharmacology of Bismuth - Studies from the Royal Free Hospital
The Absorption of Bismuth from Orally Administered Tripotassium Dicitrato Bismuthate and Bismuth Subsalicylate
Pharmacokinetics of Bismuth Compounds in Patients with Gastritis and Ulcer Disease During Standard Treatment
Discussion
Pharmacology and Safety of Bismuth Compounds
Discussion
Section 4 Clinical Trials for Helicobacter pylori Treatment
Treatment Regimens to Eradicate Helicobacter pylori
Discussion
Effect of Eradication of Helicobacter pylori on Nonulcer Dyspepsia Syndrome and Chronic Gastritis
Discussion
Section 5 Optimal Design of Clinical Trials
Histological Definition and Scoring of Gastritis
Discussion
Measuring Symptoms in Helicobacter pylori-Associated Gastritis and Non-Ulcer Dyspepsia
Discussion
Optimal Study Design for Therapeutic Trials in Helicobacter pylori- Associated Nonulcer Dyspepsia
Discussion
Optimal Design for Peptic Ulcer Studies
Discussion.